[go: up one dir, main page]

WO2007086900A3 - Stilbazium research assays - Google Patents

Stilbazium research assays Download PDF

Info

Publication number
WO2007086900A3
WO2007086900A3 PCT/US2006/012942 US2006012942W WO2007086900A3 WO 2007086900 A3 WO2007086900 A3 WO 2007086900A3 US 2006012942 W US2006012942 W US 2006012942W WO 2007086900 A3 WO2007086900 A3 WO 2007086900A3
Authority
WO
WIPO (PCT)
Prior art keywords
stilbazium
research assays
assays
research
fluoresce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/012942
Other languages
French (fr)
Other versions
WO2007086900A2 (en
Inventor
Jeffrey L Selph
Jayendra Sharma
John J Partridge
Richard B Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mycosol Inc
Original Assignee
Mycosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycosol Inc filed Critical Mycosol Inc
Priority to CA002603869A priority Critical patent/CA2603869A1/en
Priority to JP2008505550A priority patent/JP2009501511A/en
Priority to AU2006336403A priority patent/AU2006336403A1/en
Priority to BRPI0607912A priority patent/BRPI0607912A2/en
Priority to MX2007012486A priority patent/MX2007012486A/en
Priority to EP06849752A priority patent/EP1875654A2/en
Publication of WO2007086900A2 publication Critical patent/WO2007086900A2/en
Priority to IL186425A priority patent/IL186425A0/en
Anticipated expiration legal-status Critical
Publication of WO2007086900A3 publication Critical patent/WO2007086900A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Computer Security & Cryptography (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Methods for determining the presence, absence, health or interaction between cells analytes, nucleic acids or microorganisms in a sample are provided. Compounds that fluoresce and kits containing the same are also provided.
PCT/US2006/012942 2005-04-08 2006-04-07 Stilbazium research assays Ceased WO2007086900A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002603869A CA2603869A1 (en) 2005-04-08 2006-04-07 Stilbazium research assays
JP2008505550A JP2009501511A (en) 2005-04-08 2006-04-07 Stilbadium Research Assay
AU2006336403A AU2006336403A1 (en) 2005-04-08 2006-04-07 Stilbazium research assays
BRPI0607912A BRPI0607912A2 (en) 2005-04-08 2006-04-07 Assay for the presence, absence, or health of a cell, analyte, nucleic acid, or microorganism in a sample, probe, methods for selecting an analyte that binds to a compound to determine whether a nucleic acid of interest interacts with a interest in a cell or sample, and to determine the presence or absence of one or more target compounds in a sample, kit for staining cells, analytes, nucleic acids or microorganisms in a sample, and, "
MX2007012486A MX2007012486A (en) 2005-04-08 2006-04-07 Stilbazium research assays.
EP06849752A EP1875654A2 (en) 2005-04-08 2006-04-07 Stilbazium research assays
IL186425A IL186425A0 (en) 2005-04-08 2007-10-07 Stilbazium research assays

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US66961505P 2005-04-08 2005-04-08
US60/669,615 2005-04-08
US73451805P 2005-11-08 2005-11-08
US60/734,518 2005-11-08
US77336606P 2006-02-13 2006-02-13
US60/773,366 2006-02-13

Publications (2)

Publication Number Publication Date
WO2007086900A2 WO2007086900A2 (en) 2007-08-02
WO2007086900A3 true WO2007086900A3 (en) 2009-04-16

Family

ID=38309649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/012942 Ceased WO2007086900A2 (en) 2005-04-08 2006-04-07 Stilbazium research assays

Country Status (9)

Country Link
EP (1) EP1875654A2 (en)
JP (1) JP2009501511A (en)
KR (1) KR20080003402A (en)
AU (1) AU2006336403A1 (en)
BR (1) BRPI0607912A2 (en)
CA (1) CA2603869A1 (en)
IL (1) IL186425A0 (en)
MX (1) MX2007012486A (en)
WO (1) WO2007086900A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501791B2 (en) 2011-10-14 2019-12-10 President And Fellows Of Harvard College Sequencing by structure assembly
ES2991004T3 (en) 2011-12-22 2024-12-02 Harvard College Methods for the detection of analytes
CA2859761C (en) 2011-12-22 2023-06-20 President And Fellows Of Harvard College Compositions and methods for analyte detection
WO2014163886A1 (en) 2013-03-12 2014-10-09 President And Fellows Of Harvard College Method of generating a three-dimensional nucleic acid containing matrix
WO2013184754A2 (en) 2012-06-05 2013-12-12 President And Fellows Of Harvard College Spatial sequencing of nucleic acids using dna origami probes
MX385330B (en) 2013-06-04 2025-03-18 Harvard College RIBONUCLEIC ACID-GUIDED TRANSCRIPTIONAL REGULATION.
US10179932B2 (en) 2014-07-11 2019-01-15 President And Fellows Of Harvard College Methods for high-throughput labelling and detection of biological features in situ using microscopy
CA3004285A1 (en) 2015-11-03 2017-05-11 President And Fellows Of Harvard College Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix
WO2017189525A1 (en) 2016-04-25 2017-11-02 President And Fellows Of Harvard College Hybridization chain reaction methods for in situ molecular detection
JP7239465B2 (en) 2016-08-31 2023-03-14 プレジデント アンド フェローズ オブ ハーバード カレッジ Methods for preparing nucleic acid sequence libraries for detection by fluorescence in situ sequencing
CN109923216B (en) 2016-08-31 2024-08-02 哈佛学院董事及会员团体 Methods for combining detection of biomolecules into a single assay using fluorescent in situ sequencing
CA3019250A1 (en) 2017-04-14 2019-10-13 President And Fellows Of Harvard College Methods for generation of cell-derived microfilament network
EP3836967A4 (en) 2018-07-30 2022-06-15 ReadCoor, LLC METHODS AND SYSTEMS FOR SAMPLE PROCESSING OR ANALYSIS
WO2020076976A1 (en) 2018-10-10 2020-04-16 Readcoor, Inc. Three-dimensional spatial molecular indexing
US20220049303A1 (en) 2020-08-17 2022-02-17 Readcoor, Llc Methods and systems for spatial mapping of genetic variants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US7220761B2 (en) * 2003-03-03 2007-05-22 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US7220761B2 (en) * 2003-03-03 2007-05-22 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects

Also Published As

Publication number Publication date
IL186425A0 (en) 2008-01-20
MX2007012486A (en) 2007-12-13
JP2009501511A (en) 2009-01-22
AU2006336403A1 (en) 2007-08-02
WO2007086900A2 (en) 2007-08-02
CA2603869A1 (en) 2007-08-02
BRPI0607912A2 (en) 2016-11-01
KR20080003402A (en) 2008-01-07
EP1875654A2 (en) 2008-01-09

Similar Documents

Publication Publication Date Title
EP2484781A3 (en) Detection of analytes and nucleic acids
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2009058902A3 (en) Methods and devices for analyte detection
WO2006121997A3 (en) Self-contained biological analysis
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2007086900A3 (en) Stilbazium research assays
ZA200610116B (en) Voltammetric systems for assaying biological analytes
WO2003062462A3 (en) Method for isolating nucleic acids and protein from a single sample
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
WO2005068628A3 (en) Methods for nucleic acid isolation and kits using solid phase material
WO2006117161A3 (en) New labelling strategies for the sensitive detection of analytes
WO2005003394A3 (en) Bio-barcode based detection of target analytes
WO2010065781A3 (en) Lateral flow strip assay with immobilized conjugate
WO2005106036A3 (en) Methods and compositions for assaying analytes
WO2004022785A3 (en) Methods detecting, characterising and monitoring hydrocarbon reservoirs
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
WO2007035929A3 (en) Method for detecting and quantitating multiple subcellular components
WO2008124091A3 (en) Compositions and methods of detection
WO2007021756A3 (en) Methods for characterizing biological molecule modulators
WO2009129472A3 (en) Methods of labeling biological samples
WO2006086737A3 (en) Mir-155 assay
WO2004010143A3 (en) Electrochemical lateral flow and flow-through devices
WO2005031004A3 (en) Method for the specific rapid detection of beverage-spoiling micro-organisms
WO2004043227A3 (en) Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae
GB2423266B (en) An analyte assay structure in microfluidic chip for quantitative analysis and method for using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680020332.X

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2603869

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/012486

Country of ref document: MX

Ref document number: 7647/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 186425

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2008505550

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006336403

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006336403

Country of ref document: AU

Date of ref document: 20060407

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020077025630

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2006849752

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007141408

Country of ref document: RU

ENP Entry into the national phase

Ref document number: PI0607912

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20071005